|
Chronic respiratory diseases group (model1)
|
1.04 (0.99, 1.09)
|
0.156
|
|
Chronic respiratory diseases: sensitivity analyses (model2)
| | |
|
COPD
|
0.96 (0.85, 1.09)
|
0.553
|
|
Asthma
|
1.01 (0.96, 1.07)
|
0.464
|
|
Interstitial lung disease
|
1.63 (1.17, 2.26)
|
0.004
|
|
Lung cancer
|
0.91 (0.67, 1.23)
|
0.533
|
|
Lung disease d/t external agent
|
1.35 (0.99, 1.85)
|
0.061
|
|
Obstructive sleep apnea
|
1.65 (1.23, 2.16)
|
< 0.001
|
|
Tuberculosis of lung
|
0.92 (0.75, 1.11)
|
0.372
|
|
Age, year
| | |
|
20–29
|
1
| |
|
30–39
|
0.94 (0.86, 1.02)
|
0.153
|
|
40–49
|
0.86 (0.80, 0.93)
|
< 0.001
|
|
50–59
|
0.74 (0.69, 0.79)
|
< 0.001
|
|
60–69
|
0.60 (0.55, 0.66)
|
< 0.001
|
|
70–79
|
0.47 (0.42, 0.52)
|
< 0.001
|
|
≥ 80
|
0.38 (0.33, 0.44)
|
< 0.001
|
|
Income level
| | |
|
Q1 (Lowest)
|
1
| |
|
Q2
|
0.80 (0.75, 0.86)
|
< 0.001
|
|
Q3
|
0.78 (0.73, 0.83)
|
< 0.001
|
|
Q4 (Highest)
|
0.83 (0.78, 0.88)
|
< 0.001
|
|
Unknown
|
0.75 (0.62, 0.91)
|
0.004
|
|
Sex, male
|
1.01 (0.96, 1.06)
|
0.678
|
|
Residence
| | |
|
Seoul
|
1
| |
|
Gyeonggi-do
|
0.90 (0.82, 0.99)
|
0.038
|
|
Daegu
|
0.96 (0.84, 1.10)
|
0.562
|
|
Gyeongsangbuk-do
|
0.94 (0.84, 1.05)
|
0.271
|
|
Other area
|
0.89 (0.79, 1.00)
|
0.053
|
|
Underlying disability
|
1.11 (1.00, 1.22)
|
0.041
|
|
Charlson comorbidity index (model 2)
|
1.19 (1.18, 1.20)
|
< 0.0001
|
|
Hypertension
|
0.80 (0.74, 0.85)
|
< 0.001
|
|
DM without chronic complication
|
1.75 (1.63, 1.88)
|
< 0.001
|
|
DM with chronic complication
|
0.81 (0.71, 0.92)
|
0.001
|
|
Peripheral vascular disease
|
0.75 (0.67, 0.83)
|
< 0.001
|
|
Renal disease
|
0.91 (0.75, 1.11)
|
0.371
|
|
Rheumatic disease
|
0.98 (0.85, 1.12)
|
0.734
|
|
Dementia
|
1.96 (1.72, 2.22)
|
< 0.001
|
|
Peptic ulcer disease
|
1.48 (1.37, 1.59)
|
< 0.001
|
|
Hemiplegia or paraplegia
|
2.69 (2.11, 3.44)
|
< 0.001
|
|
Moderate or severe liver disease
|
0.59 (0.33, 1.06)
|
0.076
|
|
Mild liver disease
|
2.12 (1.99, 2.27)
|
< 0.001
|
|
Cerebrovascular disease
|
0.99 (0.88, 1.11)
|
0.886
|
|
Congestive heart failure
|
2.88 (2.60, 3.19)
|
< 0.001
|
|
Myocardial infarction
|
4.55 (3.95, 5.24)
|
< 0.001
|
|
Malignancy
|
2.04 (1.93, 2.15)
|
< 0.001
|
|
Metastatic solid tumor
|
0.95 (0.84, 1.07)
|
0.387
|
|
AIDS/HIV
|
4.21 (1.84, 9.64)
|
< 0.001
|